---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-115011"
form_type: "8-K"
ticker: "QURE"
cik: "0001590560"
company_name: "uniQure N.V."
filed_at: "2023-11-07T23:59:59+00:00"
generated_at: "2026-06-08T15:24:08.411149+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# uniQure Q3 net loss widens to $89.6M ($1.88/sh); cash at $659M

## Summary
- Net loss of $89.6M ($1.88 diluted EPS) vs $47.9M ($1.02 EPS) in Q3 2022; revenue flat at $1.4M.
- Cash and investments $658.9M as of Sept 30, 2023; $180M cost savings expected to fund ops into Q2 2027.
- FDA cleared IND for AMT-260 (epilepsy); AMT-130 (Huntington's) update expected later Q4 2023.
- Strategic reorganization: 28% workforce cut, CSO Ricardo Dolmetsch departs, Richard Porter becomes Chief Business & Scientific Officer.
- Received $100M milestone from CSL for first U.S. HEMGENIX sale; won 2023 Prix Galien USA Award.

## SEC filing metadata
- accession: 0001104659-23-115011
- form_type: 8-K
- ticker: QURE
- cik: 0001590560
- company_name: uniQure N.V.
- filed_at: 2023-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1590560/000110465923115011/0001104659-23-115011-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1590560/000110465923115011/tm2330023d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-115011
- JSON: https://secwatch.observer/filing/0001104659-23-115011.json
- Plain text: https://secwatch.observer/filing/0001104659-23-115011.txt

## Key facts
- Earnings Releases
  uniQure N.V. reported financial results for the quarter ended September 30, 2023.
  - Period: the quarter ended September 30, 2023
  - Result: reported results
  source text: On November 7, 2023, uniQure N.V. (the “Company”) issued a press release announcing its financial results for the quarter ended September 30, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1590560/000110465923115011/0001104659-23-115011-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.